The FDA designation follows positive Phase II data announced recently.
Century Therapeutics will pay $35m upfront and an additional $10m milestone paym...
Discover the groundbreaking patent by Kyowa Kirin Co Ltd for a monoclonal antibo...
Discover a groundbreaking patent by MorphoSys AG for novel compounds targeting m...
ADMA Biologics Inc's innovative method for treating upper respiratory infections...
Innate Pharma plans to advance IPH45 towards clinical trials, with an investigat...
Novartis lays off 680 staff members in the US and Switzerland following a succes...
The FDA has granted orphan drug designation for Lisata Therapeutics’s LSTA1 (cer...
TORL plans to use the funds to advance the clinical development of its antibody-...
Discover how Acceleron Pharma's patent for treating spinal muscular atrophy with...
From nanoparticles to transdermal patches, Pharmaceutical Technology takes a loo...
Pharmaceutical Technology has listed the leading suppliers of pharmaceutical cle...
Sensorion expects results from a Phase I/II trial of its lead candidate SENS-501...
AdAlta has signed an MOU with SYNthesis to explore the creation of a jointly own...
Medicxi has partnered with Starpharma for the formation of Petalion Therapeutics...
Bristol Myers Squibb (BMS) and 2seventy bio’s Abecma have received FDA approval ...
